CORT - Corcept Therapeutics GAAP EPS of $0.15 misses by $0.08 revenue of $103M misses by $2.08M
- Corcept Therapeutics press release ( NASDAQ: CORT ): Q4 GAAP EPS of $0.15 misses by $0.08 .
- Revenue of $103M (+4.3% Y/Y) misses by $2.08M .
- 2023 revenue guidance of $430 – $450 million
For further details see:
Corcept Therapeutics GAAP EPS of $0.15 misses by $0.08, revenue of $103M misses by $2.08M